Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)-a veterinary cooperative oncology group (VCOG) consensus document

David M. Vail, Gina Μ. Michels, C. Khanna, +2

Veterinary and Comparative Oncology

Lymphoid NeoplasiaConsensus DocumentMedicinePeripheral Nodal LymphomaVcog Membership +11

An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential

C. Khanna, Jennifer Prehn, Choh Yeung, +3

Clinical & Experimental Metastasis

Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells

Güllay Bulut, S.‐H. Hong, Kunli Chen, +10

Oncogene

Small Molecule InhibitorsMedicinePharmacologyOsteosarcoma CellsCell-matrix Interaction +6

Mitochondrial retrograde signaling induces epithelial–mesenchymal transition and generates breast cancer stem cells

Manti Guha, Satish Srinivasan, Gordon Ruthel, +6

Oncogene

Developmental BiologyMitochondrial FunctionMitochondrial DynamicMedicineInduces Epithelial–mesenchymal Transition +10

The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC

Ling Ren, Soonwoo Hong, Jessica Cassavaugh, +6

Oncogene

Bone Morphogenic ProteinOsteosarcoma MetastasisCell-matrix InteractionCytoskeletonRadiation Oncology +5

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

Zhou Wang, Bin Zhu, Mingjie Zhang, +341

Human Molecular Genetics

Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin

Xiaolin Wan, So Young Kim, Lillian M. Guenther, +11

Oncogene

Tumor BiologyCell-matrix InteractionBeta4 IntegrinMatrix BiologyMedicine +2

Aerosol delivery of interleukin 2 liposomes is nontoxic and biologically effective: canine studies.

C. Khanna, Diane E. Hasz, Jeffrey S. Klausner, +1

PubMed

InflammationCytokineCanine StudiesAerosol DeliveryInterleukin 2 +12

Pretreatment with a monoclonal antibody/interleukin-2 fusion protein directed against DNA enhances the delivery of therapeutic molecules to solid tumors.

Jason L. Hornick, Leslie A. Khawli, Peisheng Hu, +3

PubMed

Solid TumorsNitric OxideImmunologyImmunoeditingImmunotherapy +15

Phase I Clinical Evaluation of Carboplatin in Tumor-Bearing Cats: A Veterinary Cooperative Oncology Group Study

William C. Kisseberth, David M. Vail, Jill E. Yaissle, +5

Journal of Veterinary Internal Medicine